APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Heart Failure Drugs

Heart failure occurs when your heart muscle doesn't pump blood as well as it should.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Heart failure occurs when your heart muscle doesn't pump blood as well as it should.

Selected research

Industry Growth & Trends

Global Heart Failure Drugs Industry Growth and Trends Forecast to 2032

Report ID 173997220130 December 2025109 pages

Choose your research edition.

Industry ResearchHeart Failure Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Heart Failure Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Heart Failure Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Heart Failure Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Heart Failure Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Heart failure occurs when your heart muscle doesn't pump blood as well as it should.

The market is concentrated as Novartis, Pfizer, AstraZeneca , Hikma, Teva etc. Turkey is the largest consumption place in the Turkey and Middle East & Africa market, with a consumption market share nearly 21%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Heart Failure Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Heart Failure Drugs market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Heart Failure Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Heart Failure Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Heart Failure Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Heart Failure Drugs Market by Company

Novartis

Pfizer

AstraZeneca

Hikma

Teva

Cipla

Merck & Co.

Amgen

Roche

Sun Pharma

Mylan

Heart Failure Drugs Segment by Type

ACEI

Angiotensin II Receptor Blockers

ARNIs

Beta Blockers

Aldosterone Antagonists

Diuretics

Heart Failure Drugs Segment by Application

Reduced Ejection Fraction

Preserved Ejection Fraction

Heart Failure Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heart Failure Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Heart Failure Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heart Failure Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Heart Failure Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Heart Failure Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ACEI Table 2. Major Company of Angiotensin II Receptor Blockers Table 3. Major Company of ARNIs Table 4. Major Company of Beta Blockers Table 5. Major Company of Aldosterone Antagonists Table 6. Major Company of Diuretics Table 7. Global Heart Failure Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Heart Failure Drugs Sales by Type (2021-2026) & (MT) Table 9. Global Heart Failure Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global Heart Failure Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global Heart Failure Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global Heart Failure Drugs Price by Type (2021-2026) & (USD/MT) Table 13. Global Heart Failure Drugs Sales by Type (2027-2032) & (MT) Table 14. Global Heart Failure Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global Heart Failure Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global Heart Failure Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global Heart Failure Drugs Price by Type (2027-2032) & (USD/MT) Table 18. North America Heart Failure Drugs Sales by Type (2021-2026) & (MT) Table 19. North America Heart Failure Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Heart Failure Drugs Sales by Type (2021-2026) & (MT) Table 21. Europe Heart Failure Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Heart Failure Drugs Sales by Type (2021-2026) & (MT) Table 23. Asia-Pacific Heart Failure Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Heart Failure Drugs Sales by Type (2021-2026) & (MT) Table 25. Latin America Heart Failure Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Heart Failure Drugs Sales by Type (2021-2026) & (MT) Table 27. Middle East and Africa Heart Failure Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Heart Failure Drugs Industry Trends Table 29. Heart Failure Drugs Industry Drivers Table 30. Heart Failure Drugs Industry Opportunities and Challenges Table 31. Heart Failure Drugs Industry Restraints Table 32. Global Heart Failure Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Heart Failure Drugs Revenue Market Share by Company (2021-2026) Table 34. Global Heart Failure Drugs Sales by Company (2021-2026) & (MT) Table 35. Global Heart Failure Drugs Sales Share by Company (2021-2026) Table 36. Global Heart Failure Drugs Market Price by Company (2021-2026) & (USD/MT) Table 37. Global Heart Failure Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Heart Failure Drugs Major Company Production Sites and Headquarters Table 39. Global Heart Failure Drugs Company, Product Type & Application Table 40. Global Heart Failure Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Heart Failure Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Heart Failure Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Heart Failure Drugs Sales by Region (2021-2026) & (MT) Table 45. Global Heart Failure Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global Heart Failure Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global Heart Failure Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global Heart Failure Drugs Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 49. Global Heart Failure Drugs Sales by Region (2027-2032) & (MT) Table 50. Global Heart Failure Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global Heart Failure Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global Heart Failure Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global Heart Failure Drugs Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2027-2032) Table 54. Global Heart Failure Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Heart Failure Drugs Sales by Application (2021-2026) & (MT) Table 56. Global Heart Failure Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global Heart Failure Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global Heart Failure Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global Heart Failure Drugs Price by Application (2021-2026) & (USD/MT) Table 60. Global Heart Failure Drugs Sales by Application (2027-2032) & (MT) Table 61. Global Heart Failure Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global Heart Failure Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global Heart Failure Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global Heart Failure Drugs Price by Application (2027-2032) & (USD/MT) Table 65. North America Heart Failure Drugs Sales by Application (2021-2026) & (MT) Table 66. North America Heart Failure Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Heart Failure Drugs Sales by Application (2021-2026) & (MT) Table 68. Europe Heart Failure Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Heart Failure Drugs Sales by Application (2021-2026) & (MT) Table 70. Asia-Pacific Heart Failure Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Heart Failure Drugs Sales by Application (2021-2026) & (MT) Table 72. Latin America Heart Failure Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Heart Failure Drugs Sales by Application (2021-2026) & (MT) Table 74. Middle East and Africa Heart Failure Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 78. Novartis Heart Failure Drugs Product Portfolio Table 79. Novartis Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 83. Pfizer Heart Failure Drugs Product Portfolio Table 84. Pfizer Recent Development Table 85. AstraZeneca Company Information Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 88. AstraZeneca Heart Failure Drugs Product Portfolio Table 89. AstraZeneca Recent Development Table 90. Hikma Company Information Table 91. Hikma Business Overview Table 92. Hikma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 93. Hikma Heart Failure Drugs Product Portfolio Table 94. Hikma Recent Development Table 95. Teva Company Information Table 96. Teva Business Overview Table 97. Teva Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 98. Teva Heart Failure Drugs Product Portfolio Table 99. Teva Recent Development Table 100. Cipla Company Information Table 101. Cipla Business Overview Table 102. Cipla Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 103. Cipla Heart Failure Drugs Product Portfolio Table 104. Cipla Recent Development Table 105. Merck & Co. Company Information Table 106. Merck & Co. Business Overview Table 107. Merck & Co. Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 108. Merck & Co. Heart Failure Drugs Product Portfolio Table 109. Merck & Co. Recent Development Table 110. Amgen Company Information Table 111. Amgen Business Overview Table 112. Amgen Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 113. Amgen Heart Failure Drugs Product Portfolio Table 114. Amgen Recent Development Table 115. Roche Company Information Table 116. Roche Business Overview Table 117. Roche Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 118. Roche Heart Failure Drugs Product Portfolio Table 119. Roche Recent Development Table 120. Sun Pharma Company Information Table 121. Sun Pharma Business Overview Table 122. Sun Pharma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 123. Sun Pharma Heart Failure Drugs Product Portfolio Table 124. Sun Pharma Recent Development Table 125. Mylan Company Information Table 126. Mylan Business Overview Table 127. Mylan Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 128. Mylan Heart Failure Drugs Product Portfolio Table 129. Mylan Recent Development Table 130. North America Heart Failure Drugs Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 131. North America Heart Failure Drugs Sales by Country (2021-2026) & (MT) Table 132. North America Heart Failure Drugs Sales Market Share by Country (2021-2026) Table 133. North America Heart Failure Drugs Sales Forecast by Country (2027-2032) & (MT) Table 134. North America Heart Failure Drugs Sales Market Share Forecast by Country (2027-2032) Table 135. North America Heart Failure Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. North America Heart Failure Drugs Market Size by Country (2021-2026) & (US$ Million) Table 137. North America Heart Failure Drugs Market Share by Country (2021-2026) Table 138. North America Heart Failure Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. North America Heart Failure Drugs Market Share Forecast by Country (2027-2032) Table 140. Europe Heart Failure Drugs Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 141. Europe Heart Failure Drugs Sales by Country (2021-2026) & (MT) Table 142. Europe Heart Failure Drugs Sales Market Share by Country (2021-2026) Table 143. Europe Heart Failure Drugs Sales Forecast by Country (2027-2032) & (MT) Table 144. Europe Heart Failure Drugs Sales Market Share Forecast by Country (2027-2032) Table 145. Europe Heart Failure Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Europe Heart Failure Drugs Market Size by Country (2021-2026) & (US$ Million) Table 147. Europe Heart Failure Drugs Market Share by Country (2021-2026) Table 148. Europe Heart Failure Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Europe Heart Failure Drugs Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Heart Failure Drugs Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Heart Failure Drugs Sales by Country (2021-2026) & (MT) Table 152. Asia-Pacific Heart Failure Drugs Sales Market Share by Country (2021-2026) Table 153. Asia-Pacific Heart Failure Drugs Sales Forecast by Country (2027-2032) & (MT) Table 154. Asia-Pacific Heart Failure Drugs Sales Market Share Forecast by Country (2027-2032) Table 155. Asia-Pacific Heart Failure Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Asia-Pacific Heart Failure Drugs Market Size by Country (2021-2026) & (US$ Million) Table 157. Asia-Pacific Heart Failure Drugs Market Share by Country (2021-2026) Table 158. Asia-Pacific Heart Failure Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Asia-Pacific Heart Failure Drugs Market Share Forecast by Country (2027-2032) Table 160. Latin America Heart Failure Drugs Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 161. Latin America Heart Failure Drugs Sales by Country (2021-2026) & (MT) Table 162. Latin America Heart Failure Drugs Sales Market Share by Country (2021-2026) Table 163. Latin America Heart Failure Drugs Sales Forecast by Country (2027-2032) & (MT) Table 164. Latin America Heart Failure Drugs Sales Market Share Forecast by Country (2027-2032) Table 165. Latin America Heart Failure Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Latin America Heart Failure Drugs Market Size by Country (2021-2026) & (US$ Million) Table 167. Latin America Heart Failure Drugs Market Share by Country (2021-2026) Table 168. Latin America Heart Failure Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Latin America Heart Failure Drugs Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Heart Failure Drugs Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Heart Failure Drugs Sales by Country (2021-2026) & (MT) Table 172. Middle East and Africa Heart Failure Drugs Sales Market Share by Country (2021-2026) Table 173. Middle East and Africa Heart Failure Drugs Sales Forecast by Country (2027-2032) & (MT) Table 174. Middle East and Africa Heart Failure Drugs Sales Market Share Forecast by Country (2027-2032) Table 175. Middle East and Africa Heart Failure Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 176. Middle East and Africa Heart Failure Drugs Market Size by Country (2021-2026) & (US$ Million) Table 177. Middle East and Africa Heart Failure Drugs Market Share by Country (2021-2026) Table 178. Middle East and Africa Heart Failure Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 179. Middle East and Africa Heart Failure Drugs Market Share Forecast by Country (2027-2032) Table 180. Key Raw Materials Table 181. Raw Materials Key Suppliers Table 182. Heart Failure Drugs Distributors List Table 183. Heart Failure Drugs Customers List Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Heart Failure Drugs Image Figure 2. Global Heart Failure Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Heart Failure Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Heart Failure Drugs Sales (2021-2032) & (MT) Figure 5. ACEI Image Figure 6. Global ACEI Sales YoY Growth (2021-2032) & (MT) Figure 7. Angiotensin II Receptor Blockers Image Figure 8. Global Angiotensin II Receptor Blockers Sales YoY Growth (2021-2032) & (MT) Figure 9. ARNIs Image Figure 10. Global ARNIs Sales YoY Growth (2021-2032) & (MT) Figure 11. Beta Blockers Image Figure 12. Global Beta Blockers Sales YoY Growth (2021-2032) & (MT) Figure 13. Aldosterone Antagonists Image Figure 14. Global Aldosterone Antagonists Sales YoY Growth (2021-2032) & (MT) Figure 15. Diuretics Image Figure 16. Global Diuretics Sales YoY Growth (2021-2032) & (MT) Figure 17. Global Heart Failure Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Heart Failure Drugs Market Share by Type 2025 VS 2032 Figure 19. North America Heart Failure Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America Heart Failure Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe Heart Failure Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe Heart Failure Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Heart Failure Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Heart Failure Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America Heart Failure Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Heart Failure Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Heart Failure Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Heart Failure Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Heart Failure Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Reduced Ejection Fraction Image Figure 32. Global Reduced Ejection Fraction Sales YoY Growth (2021-2032) & (MT) Figure 33. Preserved Ejection Fraction Image Figure 34. Global Preserved Ejection Fraction Sales YoY Growth (2021-2032) & (MT) Figure 35. Global Heart Failure Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Heart Failure Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Heart Failure Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Heart Failure Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Heart Failure Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Heart Failure Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Heart Failure Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Heart Failure Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Heart Failure Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Heart Failure Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Heart Failure Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Heart Failure Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Heart Failure Drugs Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 48. North America Heart Failure Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Heart Failure Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Heart Failure Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Heart Failure Drugs Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 52. Europe Heart Failure Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Heart Failure Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Heart Failure Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Heart Failure Drugs Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 56. Asia-Pacific Heart Failure Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Heart Failure Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Heart Failure Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Heart Failure Drugs Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 60. Latin America Heart Failure Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Heart Failure Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Heart Failure Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Heart Failure Drugs Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 64. Middle East and Africa Heart Failure Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Heart Failure Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Heart Failure Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Heart Failure Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Heart Failure Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • ACEI
  • Angiotensin II Receptor Blockers
  • ARNIs
  • Beta Blockers
  • Aldosterone Antagonists
  • Diuretics
Applications
  • Reduced Ejection Fraction
  • Preserved Ejection Fraction
Companies covered
  • Novartis
  • Pfizer
  • AstraZeneca
  • Hikma
  • Teva
  • Cipla
  • Merck & Co.
  • Amgen
  • Roche
  • Sun Pharma
  • Mylan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Heart Failure Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Heart Failure Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Heart Failure Drugs Market by Type
  6. 1.3.1 ACEI
  7. 1.3.2 Angiotensin II Receptor Blockers
  8. 1.3.3 ARNIs
  9. 1.3.4 Beta Blockers
  10. 1.3.5 Aldosterone Antagonists
  11. 1.3.6 Diuretics
  12. 1.4 Global Heart Failure Drugs Market Size by Type
  13. 1.4.1 Global Heart Failure Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Heart Failure Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Heart Failure Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Heart Failure Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Heart Failure Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Heart Failure Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Heart Failure Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Heart Failure Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Heart Failure Drugs Industry Trends
  2. 2.2 Heart Failure Drugs Industry Drivers
  3. 2.3 Heart Failure Drugs Industry Opportunities and Challenges
  4. 2.4 Heart Failure Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Heart Failure Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Heart Failure Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Heart Failure Drugs Price (2021-2026)
  4. 3.4 Global Heart Failure Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Heart Failure Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Heart Failure Drugs Company, Product Type & Application
  7. 3.7 Global Heart Failure Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Heart Failure Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Heart Failure Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Heart Failure Drugs Tier 1, Tier 2, and Tier 3
4 Heart Failure Drugs Regional Status and Outlook
  1. 4.1 Global Heart Failure Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Heart Failure Drugs Historic Market Size by Region
  3. 4.2.1 Global Heart Failure Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Heart Failure Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Heart Failure Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Heart Failure Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Heart Failure Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Heart Failure Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Heart Failure Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Heart Failure Drugs by Application
  1. 5.1 Heart Failure Drugs Market by Application
  2. 5.1.1 Reduced Ejection Fraction
  3. 5.1.2 Preserved Ejection Fraction
  4. 5.2 Global Heart Failure Drugs Market Size by Application
  5. 5.2.1 Global Heart Failure Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Heart Failure Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Heart Failure Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Heart Failure Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Heart Failure Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Heart Failure Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Heart Failure Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Heart Failure Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Heart Failure Drugs Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Heart Failure Drugs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 AstraZeneca
  14. 6.3.1 AstraZeneca Company Information
  15. 6.3.2 AstraZeneca Business Overview
  16. 6.3.3 AstraZeneca Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Heart Failure Drugs Product Portfolio
  18. 6.3.5 AstraZeneca Recent Developments
  19. 6.4 Hikma
  20. 6.4.1 Hikma Company Information
  21. 6.4.2 Hikma Business Overview
  22. 6.4.3 Hikma Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hikma Heart Failure Drugs Product Portfolio
  24. 6.4.5 Hikma Recent Developments
  25. 6.5 Teva
  26. 6.5.1 Teva Company Information
  27. 6.5.2 Teva Business Overview
  28. 6.5.3 Teva Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva Heart Failure Drugs Product Portfolio
  30. 6.5.5 Teva Recent Developments
  31. 6.6 Cipla
  32. 6.6.1 Cipla Company Information
  33. 6.6.2 Cipla Business Overview
  34. 6.6.3 Cipla Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cipla Heart Failure Drugs Product Portfolio
  36. 6.6.5 Cipla Recent Developments
  37. 6.7 Merck & Co.
  38. 6.7.1 Merck & Co. Company Information
  39. 6.7.2 Merck & Co. Business Overview
  40. 6.7.3 Merck & Co. Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck & Co. Heart Failure Drugs Product Portfolio
  42. 6.7.5 Merck & Co. Recent Developments
  43. 6.8 Amgen
  44. 6.8.1 Amgen Company Information
  45. 6.8.2 Amgen Business Overview
  46. 6.8.3 Amgen Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Amgen Heart Failure Drugs Product Portfolio
  48. 6.8.5 Amgen Recent Developments
  49. 6.9 Roche
  50. 6.9.1 Roche Company Information
  51. 6.9.2 Roche Business Overview
  52. 6.9.3 Roche Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Roche Heart Failure Drugs Product Portfolio
  54. 6.9.5 Roche Recent Developments
  55. 6.10 Sun Pharma
  56. 6.10.1 Sun Pharma Company Information
  57. 6.10.2 Sun Pharma Business Overview
  58. 6.10.3 Sun Pharma Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sun Pharma Heart Failure Drugs Product Portfolio
  60. 6.10.5 Sun Pharma Recent Developments
  61. 6.11 Mylan
  62. 6.11.1 Mylan Company Information
  63. 6.11.2 Mylan Business Overview
  64. 6.11.3 Mylan Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Mylan Heart Failure Drugs Product Portfolio
  66. 6.11.5 Mylan Recent Developments
7 North America by Country
  1. 7.1 North America Heart Failure Drugs Sales by Country
  2. 7.1.1 North America Heart Failure Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Heart Failure Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Heart Failure Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Heart Failure Drugs Market Size by Country
  6. 7.2.1 North America Heart Failure Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Heart Failure Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Heart Failure Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Heart Failure Drugs Sales by Country
  2. 8.1.1 Europe Heart Failure Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Heart Failure Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Heart Failure Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Heart Failure Drugs Market Size by Country
  6. 8.2.1 Europe Heart Failure Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Heart Failure Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Heart Failure Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Heart Failure Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Heart Failure Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Heart Failure Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Heart Failure Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Heart Failure Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Heart Failure Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Heart Failure Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Heart Failure Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Heart Failure Drugs Sales by Country
  2. 10.1.1 South America Heart Failure Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Heart Failure Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Heart Failure Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Heart Failure Drugs Market Size by Country
  6. 10.2.1 South America Heart Failure Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Heart Failure Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Heart Failure Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Heart Failure Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Heart Failure Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Heart Failure Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Heart Failure Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Heart Failure Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Heart Failure Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Heart Failure Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Heart Failure Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Heart Failure Drugs Value Chain Analysis
  2. 12.1.1 Heart Failure Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Heart Failure Drugs Production Mode & Process
  7. 12.2 Heart Failure Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Heart Failure Drugs Distributors
  10. 12.2.3 Heart Failure Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst